US 12239656
Nucleoporins as drug targets for anti-proliferative therapeutics
granted A61KA61K31/65A61K31/7105
Quick answer
US patent 12239656 (Nucleoporins as drug targets for anti-proliferative therapeutics) held by SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE expires Mon Feb 27 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
- Grant date
- Tue Mar 04 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 27 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61K, A61K31/65, A61K31/7105, A61K35/00, A61K45/06